+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Clinical Microbiology Market by Product (Instruments, Reagents), Specimen Type (Blood, Body fluids, Cerebrospinal Spinal Fluid), End-User, Application - Forecast 2023-2030

  • PDF Icon

    Report

  • 191 Pages
  • November 2023
  • Region: Global
  • 360iResearch™
  • ID: 5337233
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Clinical Microbiology Market size was estimated at USD 7.01 billion in 2022, USD 7.80 billion in 2023, and is expected to grow at a CAGR of 10.97% to reach USD 16.12 billion by 2030.

Clinical microbiology encompasses a wide range of testing methods, and it is complex in terms of organisms and methods used to isolate & identify them. Clinical microbiology investigates microorganisms that cause infectious diseases and focuses on isolating and characterizing infectious organisms such as bacteria, viruses, parasites, and fungi to manage and treat patients. The increasing occurence of infectious diseases, growing awareness of disease prevention, and increasing healthcare expenditure are all factors driving the use of clinical microbiology. Problems concerning quality assurance and management in clinical microbiology laboratories coupled with limited availability of equipment and infrastructure can pose a challenge to product penetration in the market. Additionally, technological advancement in clinical microbiology instruments and processes presents various opportunities for medical laboratory businesses to expand their portfolio and increase profitability.

Regional Insights

In North America, the strong presence of leading market players, increasing investments in research & development, and the growing prevalence of infectious diseases significantly increase the adoption of clinical microbiology. Highly developed pharmaceutical and healthcare sectors in the United States are fueling the adoption of advanced clinical diagnostic techniques. Developing new and innovative microbiological technologies, such as targeted polymerase chain reactions (PCRs), to increase cost-effectiveness and improve clinical outcomes is strengthening the market growth of clinical microbiology across the region. In Asia-Pacific, the growing popularity of broad-range and molecular diagnosis to surge the sensitivity of diagnosis while promoting time effectiveness significantly contributes to the development of clinical microbiology. The booming medical tourism industry is expected to increase the need for microbial diagnostic and monitoring tests in Asian countries such as India, China, Thailand, and Malaysia. In the Europe region, the increasing prevalence of pathogenic diseases, growth in the discovery of adapting bacterium, and the rising need for speedy microbiological testing methods enhance the utilization of clinical microbiology technology.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Microbiology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Microbiology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Microbiology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Instruments, LLC, Agilent Technologies, Inc., B. Braun SE, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux S.A., Cardinal Health, Inc., Clinichem Ltd., COPAN Diagnostics Inc., Diagnóstica Longwood S.L., ELITech Group, F. Hoffmann-La Roche Ltd., Hardy Diagnostics, HORIBA, Ltd., Kyokuto Pharmaceutical Industrial Co., Ltd., Laboratorios Conda, S.A., Liofilchem S.r.l., Merck KGaA, Prestige Diagnostics U.K. Ltd., Pro Lab Diagnostics Inc., QIAGEN N.V., Rapid Micro Biosystems, Inc., Shimadzu Corporation, SSI Diagnostica A/S, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., and Vircell S.L.

Market Segmentation & Coverage

This research report categorizes the Clinical Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents
  • Specimen Type
    • Blood
    • Body fluids
    • Cerebrospinal Spinal Fluid
    • Fecal
    • Saliva
    • Serum
    • Synovial Fluid
    • Urine
  • End-User
    • Academic & Research Institutes
    • Hospitals & Care Providers
    • Laboratories
  • Application
    • Autoimmune Diseases
    • Cardiology
    • Diabetes
    • Drug Testing
    • Gastrointestinal Diseases
    • Nephrology
    • Oncology
    • Periodontal Diseases
    • Respiratory Diseases
    • Sexually Transmitted Diseases
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Clinical Microbiology Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Microbiology Market?
  3. What are the technology trends and regulatory frameworks in the Clinical Microbiology Market?
  4. What is the market share of the leading vendors in the Clinical Microbiology Market?
  5. Which modes and strategic moves are suitable for entering the Clinical Microbiology Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Frequently Asked Questions about the Global Clinical Microbiology Market

What is the estimated value of the Global Clinical Microbiology Market?

The Global Clinical Microbiology Market was estimated to be valued at $7.8 Billion in 2023.

What is the growth rate of the Global Clinical Microbiology Market?

The growth rate of the Global Clinical Microbiology Market is 10.9%, with an estimated value of $16.12 Billion by 2030.

What is the forecasted size of the Global Clinical Microbiology Market?

The Global Clinical Microbiology Market is estimated to be worth $16.12 Billion by 2030.

Who are the key companies in the Global Clinical Microbiology Market?

Key companies in the Global Clinical Microbiology Market include 3M Company, Abbott Laboratories, Advanced Instruments, LLC, Agilent Technologies, Inc., B. Braun SE, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio, Rad Laboratories, Inc. and bioMérieux S.A..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Microbiology Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing use of clinical microbiology in managing and controlling infectious diseases
5.1.1.2. Favorable government and private organizations support, and initiatives in cancer diagnosis and research
5.1.2. Restraints
5.1.2.1. Limited availability of skilled professionals, equipment and infrastructure
5.1.3. Opportunities
5.1.3.1. Technological advancement in clinical microbiology products and processes
5.1.3.2. Introduction of point-of-care microbiology testing
5.1.4. Challenges
5.1.4.1. Problems concerning quality assurance and management in clinical microbiology laboratories
5.2. Market Segmentation Analysis
5.2.1. Product: Use of laboratory instruments in clinical microbiology assessments
5.2.2. Specimen Type: Preference for serum samples in serological testing to detect past or current infections
5.2.3. End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions
5.2.4. Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens
5.3. Market Trend Analysis
5.3.1. Presence of well-established market vendors with the ongoing development of advanced clinical microbiology testings
5.3.2. Prevalence of infectious disease and improvements in clinical microbiology products in APAC
5.3.3. Supportive government initiatives and ongoing research to overcome the burden of infectious diseases in the EMEA region
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
6. Clinical Microbiology Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents
7. Clinical Microbiology Market, by Specimen Type
7.1. Introduction
7.2. Blood
7.3. Body fluids
7.4. Cerebrospinal Spinal Fluid
7.5. Fecal
7.6. Saliva
7.7. Serum
7.8. Synovial Fluid
7.9. Urine
8. Clinical Microbiology Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Hospitals & Care Providers
8.4. Laboratories
9. Clinical Microbiology Market, by Application
9.1. Introduction
9.2. Autoimmune Diseases
9.3. Cardiology
9.4. Diabetes
9.5. Drug Testing
9.6. Gastrointestinal Diseases
9.7. Nephrology
9.8. Oncology
9.9. Periodontal Diseases
9.10. Respiratory Diseases
9.11. Sexually Transmitted Diseases
10. Americas Clinical Microbiology Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Clinical Microbiology Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Clinical Microbiology Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Sci-Tech Daresbury’s Perfectus Biomed Group Acquired by Global Medical Device Testing Leader NAMSA.
13.3.1.2. ValitaCell Joins Beckman Coulter Life Sciences.
13.3.1.3. Global Access Diagnostics Acquires Manufacturing Rights for IT-LEISH Rapid Diagnostic Test From Bio-Rad Laboratories.
13.3.1.4. SSI Diagnostica Continues a Strong Growth Journey.
13.3.1.5. DCN Dx Acquires Microbiological Testing Products Company Biomed Diagnostics.
13.3.1.6. bioMérieux Strengthens its Commitment to Fight Antimicrobial Resistance with the Acquisition of Specific Diagnostics, An Innovative Company Focusing on Fast AST Solutions.
13.3.1.7. Raue Advises Sonic Healthcare on the Acquisition of Diagnosticum Laboratory Group.
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore
13.3.2.2. Hardy Diagnostics Awarded Manual Microbiology Agreement With Premier, Inc.
13.3.2.3. Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Viral and Bacterial Infections.
13.3.2.4. FASTinov Collaborates with Beckman Coulter Life Sciences to Bring Ultra-Rapid 2h-AST Disruptive Technology to Clinical Microbiology Laboratories.
13.3.2.5. BD, Accelerate Diagnostics Announce Global Commercial Collaboration.
13.3.2.6. ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN.
13.3.3. New Product Launch & Enhancement
13.3.3.1. MAESTRIA, A New Generation Microbiology Middleware Developed by Biomérieux to Optimize Laboratory Workflow and Improve Patient Care.
13.3.3.2. BD Introduces Fully Automated Robotic Track System for Microbiology Labs.
13.3.3.3. Bio-Rad Expands QC Range for Abbott Diagnostic Platforms.
13.3.3.4. HORIBA Veterinary Adds New Rapid PCR Test for Difficult to Diagnose Parasite.
13.3.3.5. Hardy Diagnostics Now Offers the BioCode MDx-3000.
13.3.3.6. COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology.
13.3.4. Investment & Funding
13.3.4.1. Cambridge Start-Up Won Funding To Develop New Diagnostics.
13.3.4.2. Department of Medical Microbiology Unveils Four New Projects Worth USD 6.8 Million and New Website.
13.3.4.3. ASM Funded for Inclusive Microbiology Leaders Program.
13.3.4.4. Federal Funds Set To Boost U of A’s Ability To Handle Highly Infectious Pathogens.
13.3.4.5. Oxford Gets £122m (USD 136.63 Million) Funding for Healthcare Research.
13.3.4.6. Israel: EUR 22 Million (Usd 24.26 Million) EU Backing for Israeli Microbiology Diagnostic Player Pocared.
13.3.4.7. NIH Funded New Tuberculosis Research Advancement Centers.
13.3.5. Award, Recognition, & Expansion
13.3.5.1. Wichita State’s MDL Lab Shifting To Microbiology.
13.3.5.2. Upstate Planned To Launch A Multidisciplinary Lyme And Tick-Borne Disease Treatment Center.
13.3.5.3. SGS Launched New Microbiology Laboratory In Phoenix, Arizona.
13.3.5.4. Merck Announced Organizational Transformation of Life Science Business Sector To Strengthen Cdmo Offering And Accelerate Future Growth.
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 3M Company
14.1.2. Abbott Laboratories
14.1.3. Advanced Instruments, LLC
14.1.4. Agilent Technologies, Inc.
14.1.5. B. Braun SE
14.1.6. Beckman Coulter, Inc.
14.1.7. Becton, Dickinson and Company
14.1.8. Bio-Rad Laboratories, Inc.
14.1.9. bioMérieux S.A.
14.1.10. Cardinal Health, Inc.
14.1.11. Clinichem Ltd.
14.1.12. COPAN Diagnostics Inc.
14.1.13. Diagnóstica Longwood S.L.
14.1.14. ELITech Group
14.1.15. F. Hoffmann-La Roche Ltd.
14.1.16. Hardy Diagnostics
14.1.17. HORIBA, Ltd.
14.1.18. Kyokuto Pharmaceutical Industrial Co., Ltd.
14.1.19. Laboratorios Conda, S.A.
14.1.20. Liofilchem S.r.l.
14.1.21. Merck KGaA
14.1.22. Prestige Diagnostics U.K. Ltd.
14.1.23. Pro Lab Diagnostics Inc.
14.1.24. QIAGEN N.V.
14.1.25. Rapid Micro Biosystems, Inc.
14.1.26. Shimadzu Corporation
14.1.27. SSI Diagnostica A/S
14.1.28. TCS Biosciences Ltd.
14.1.29. Thermo Fisher Scientific Inc.
14.1.30. Vircell S.L.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. CLINICAL MICROBIOLOGY MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL MICROBIOLOGY MARKET SIZE, 2022 VS 2030
FIGURE 3. CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL MICROBIOLOGY MARKET DYNAMICS
FIGURE 7. CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2022 VS 2030 (%)
FIGURE 10. CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 12. CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 14. CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. CLINICAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 9. CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 81. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 93. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 97. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 101. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 105. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 109. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 118. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 122. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 126. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 142. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 154. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 158. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 162. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 178. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 186. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 190. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 201. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 202. CLINICAL MICROBIOLOGY MARKET LICENSE & PRICING

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Advanced Instruments, LLC
  • Agilent Technologies, Inc.
  • B. Braun SE
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux S.A.
  • Cardinal Health, Inc.
  • Clinichem Ltd.
  • COPAN Diagnostics Inc.
  • Diagnóstica Longwood S.L.
  • ELITech Group
  • F. Hoffmann-La Roche Ltd.
  • Hardy Diagnostics
  • HORIBA, Ltd.
  • Kyokuto Pharmaceutical Industrial Co., Ltd.
  • Laboratorios Conda, S.A.
  • Liofilchem S.r.l.
  • Merck KGaA
  • Prestige Diagnostics U.K. Ltd.
  • Pro Lab Diagnostics Inc.
  • QIAGEN N.V.
  • Rapid Micro Biosystems, Inc.
  • Shimadzu Corporation
  • SSI Diagnostica A/S
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific Inc.
  • Vircell S.L.

Methodology

Loading
LOADING...